Below are current clinical trials.16 studies in Kidney transplant
(open studies only).
Filter this list of studies by location, status and more.
The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function when using QPI-1002 with kidney transplants from donors older than 45 years who have brain death.
The purpose of this study of obinutuzumab administered as intravenous (IV) infusion in adults with end stage renal disease is to assess the safety and tolerability of the regimen at week 24 of the desensitization phase and at week 28 post kidney transplantation. All participants will be monitored for a minimum of 12 months following the last obinutuzumab infusion.
The specific purpose of this study is to compare the characteristics of patients at Mayo Clinic Rochester who received a living donor kidney transplant here preemptively versus those who dialyzed either less than 1 year or more than 1 year.
The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant.
The purpose of this study is to collect and share detailed clinical data from all kidney transplant recipients from 7 kidney transplant centers (Mayo Clinic, Rochester, MN; Mayo Clinic, Scottsdale, AZ; Mayo Clinic, Jacksonville, FL; Cornell University, New York, NY; University of Michigan, Ann Arbor, MI; Henry Ford, Detroit, MI; University of Pittsburgh Medical Center, Pittsburg, PA) to retrospectively and prospectively study kidney transplant recipients.
The purpose of this study is to determine if patient satisfaction with a pharmacist-video visit is non-inferior to a face-to-face, in-clinic pharmacist visit.
Aug. 15, 2017
- Wein AJ, et al., eds. Renal transplantation. Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. https://www.clinicalkey.com. Accessed April 7, 2016.
- Partnering with your transplant team: The patient's guide to transplantation. United Network for Organ Sharing. https://www.unos.org/wp-content/uploads/unos/WEPNTK.pdf. Accessed March 11, 2016.
- Treatment methods for kidney failure: Transplantation. National Institute of Diabetes and Digestive and Kidney Diseases. http://kidney.niddk.nih.gov/KUDiseases/pubs/transplant/index.aspx. Accessed March 11, 2016.
- U.S. Department of Health and Human Resources. Organ matching. http://www.organdonor.gov/about/organmatching.html. Accessed April 7, 2016.
- The kidneys and how they work. National Institute of Diabetes and Digestive and Kidney Diseases. http://kidney.niddk.nih.gov/KUDiseases/pubs/yourkidneys/index.aspx. Accessed March 11, 2016.
- Barbara Woodward Lips Patient Education Center. Kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Hart A., et al. OPTN/SRTR Annual Data Report: Kidney. American Journal of Transplantation. 2016;16:11.
- Brennan DC. HLA matching and graft survival in kidney transplantation. http://www.uptodate.com/home. Accessed April 8, 2016.
- Rossi AP, et al. Evaluation of the potential renal transplant recipient. http://www.uptodate.com/home. Accessed March 11, 2016.
- Klein CL, et al. HLA and ABO sensitization and desensitization in renal transplantation. http://www.uptodate.com/home. Accessed March 11, 2016.
- Riggin ER. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 7, 2016.
- Venkataraman V, et al. Dialysis issues prior to and after renal transplantation. http://www.uptodate.com/home. Accessed March 15, 2016.
- Rees L, et al. Overview of renal replacement therapy (RRT) for children with chronic kidney disease. http://www.uptodate.com/home. Accessed March 15, 2016.
- Kidney disease: causes. National Kidney Foundation. https://www.kidney.org/atoz/content/kidneydiscauses. Accessed April 7, 2016.
- Berns JS. Patient information: Dialysis or kidney transplantation—Which is right for me. http://www.uptodate.com/home. Accessed April 7, 2016.
- U.S. Department of Health and Human Resources. Organ transplantation. http://www.organdonor.gov/about/transplantationprocess.html. Accessed April 8, 2016.
- UNOS. Frequently asked questions about kidney transplant evaluation and listing. https://www.unos.org/wpcontent/uploads/unos/Kidney_Eval_Brochure.pdf. Accessed April 8, 2016.
- UNOS Transplant Living. Selecting a hospital. http://www.transplantliving.org/before-the-transplant/getting-on-the-list/selecting-a-hospital/. Accessed April 5, 2016.
- Living donation: Information you need to know. Transplant Living. https://www.unos.org/donation/living-donation/. Accessed March 30, 2016.
- Kidney transplant. National Kidney Foundation. Accessed April 8, 2016.
- Vella J. Risk factors for graft failure in kidney transplantation. http://www.uptodate.com/home. Accessed April 8, 2016.
- Preparing for the transplant. American Society of Transplantation. http://www.healthytransplant.com/health_maintenance/preparing_for_transplant.aspx. Accessed March 22, 2016.
- Orandi BJ, et al. Kidney transplants from incompatible live donors. New England Journal of Medicine. 2016;374:940.
- Stegall M. Dosing regimen of eculizumab added to conventional treatment in positive cross match living donor kidney transplant. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT00670774?term=eculizumab+and+mayo&rank=3. Accessed April 8, 2016.
- Heilman RL, et al. Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal. Transplantation. 2012;93:47.
- Mai ML (expert opinion). Mayo Clinic, Jacksonville, Fla. April 27, 2016.